Overview
Evidence-based recommendations on CorVue (Abbott Medical), HeartInsight (Biotronik), HeartLogic (Boston Scientific) and TriageHF (Medtronic) for algorithm-based remote monitoring in people with cardiac implantable electronic devices.
Last reviewed: 24 October 2024
This guidance replaces NICE medtech innovation briefing 298 on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failure.
Diagnostics guidance 61 has been migrated to HealthTech guidance 730.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.